When Mitochondria Become Congested: Beyond Fuel to the Machinery of Energy

When we think about mitochondrial dysfunction, we usually think about fuel.

Is enough glucose reaching the cell?

Are fatty acids being oxidized efficiently?

Is oxygen delivery adequate?

Can electrons move through the respiratory chain fast enough to maintain ATP production?

These questions are important. But they may describe only part of the problem.

A detailed review by Song, Herrmann, and Becker in Nature Reviews Molecular Cell Biology, “Quality control of the mitochondrial proteome,” highlights another flow that mitochondria must continuously manage: the movement of proteins into, through, and within the organelle. Mitochondria do not merely burn fuel. They must continually build, maintain, repair, and replace the molecular machinery that allows fuel oxidation to occur in the first place.

This adds an important dimension to our developing concept of bioenergetic impedance.

Congestion may occur not only when carbon substrates and reducing equivalents accumulate faster than mitochondria can process them. It may also occur when the import, folding, assembly, repair, and removal of mitochondrial proteins cannot keep pace with demand.

In other words, mitochondrial throughput depends both on what flows through the machinery and on whether the machinery itself can be maintained.

Mitochondria depend on a continuous stream of imported proteins

Human mitochondrial DNA encodes only 13 proteins. Yet the mitochondrial proteome contains roughly 1,500 proteins.

That means almost all mitochondrial proteins are made outside mitochondria, on cytosolic ribosomes, and then transported into the organelle.

This imported protein stream supplies enzymes and structural components required for mitochondrial metabolism, metabolite transport, protein folding, mitochondrial dynamics, signalling, and—critically—the respiratory machinery itself. Respiratory-chain complexes are particularly demanding because they must assemble proteins encoded by both nuclear and mitochondrial genomes in the correct proportions.

The cell therefore faces a major logistical challenge:

produce the proteins → keep them correctly folded for transport → deliver them to mitochondria → import them → process them → fold them → assemble them → remove anything that fails

This is not a passive process.

The TOM complex forms the principal entry gate across the outer mitochondrial membrane, while systems such as TIM23 and TIM22 transport proteins across or into the inner membrane. Import through these inner-membrane systems depends on the mitochondrial membrane potential, while mitochondrial HSP70 and other chaperones use ATP to drive import and folding.

That creates an intriguing circular dependency.

Mitochondria need functional respiratory machinery to generate the membrane potential and ATP required for protein import.

But they also need protein import to build and renew the respiratory machinery that maintains membrane potential and ATP production.

This circular relationship may matter greatly for understanding why mitochondrial dysfunction can become persistent.

Congestion is not limited to carbon

Our earlier discussion of bioenergetic congestion has focused largely on metabolic flow.

Normally:

carbon substrates → TCA cycle → NADH/FADH₂ → electron transport chain → oxygen

When downstream electron transfer cannot keep pace with upstream supply, reducing pressure rises.

NADH accumulates relative to NAD⁺.

Dehydrogenase reactions slow. TCA-cycle intermediates may accumulate or be diverted. Carbon is rerouted toward lactate, lipid synthesis, storage, or other pathways.

This is metabolic congestion: input exceeds downstream processing capacity.

The proteostasis review suggests that a remarkably similar problem can arise with mitochondrial proteins.

Normally:

nuclear gene expression → cytosolic translation → mitochondrial targeting → TOM/TIM import → folding → assembly → functional mitochondrial machinery

But precursor proteins can fail to enter mitochondria properly. They may fold prematurely, become damaged, be mistargeted, or physically stall within the protein-import channels.

The review describes several surveillance mechanisms devoted specifically to clearing these stalled proteins, including mitochondrial protein translocation-associated degradation, the mitochondrial compromised protein import response, and mitochondrial ribosome-associated quality control.

Why would cells need so many mechanisms?

Because the mitochondrial entry gate can literally become clogged.

A precursor protein that becomes trapped in the TOM complex does not merely represent one failed protein. It can obstruct the gateway required by many other mitochondrial proteins.

This is remarkably compatible with the broader principle of impedance:

Congestion emerges whenever demand or incoming flow exceeds the capacity of a downstream process to receive, transform, transport, or clear it.

For metabolic substrates, the bottleneck may be dehydrogenase activity or electron transfer.

For mitochondrial proteins, the bottleneck may be targeting, import, folding, assembly, or degradation.

The molecules are different.

The systems principle is similar.

From substrate congestion to mitochondrial throughput congestion

It may therefore be useful to distinguish several interacting forms of mitochondrial congestion.

Metabolic congestion occurs when carbon and reducing equivalents arrive faster than oxidative metabolism can process them.

Electron-transfer congestion occurs when respiratory-chain throughput becomes limiting, generating redox backpressure.

Proteostatic congestion occurs when mitochondrial precursor delivery exceeds the capacity for import, folding, assembly, or degradation.

Repair and turnover congestion occurs when damaged mitochondrial components accumulate faster than quality-control systems can restore or remove them.

These processes interact continuously.

Imagine, for example, an initial reduction in respiratory-chain efficiency.

Electron transfer slows.

Membrane potential becomes harder to sustain.

Because mitochondrial protein import depends partly on membrane potential, protein import may then become less efficient.

Less efficient import compromises the renewal and assembly of mitochondrial enzymes and respiratory-chain components.

This further reduces respiratory capacity.

The sequence becomes:

impaired ETC throughput→ lower membrane potential→ impaired mitochondrial protein import→ poorer respiratory machinery renewal→ still lower ETC capacity

At the same time, failed protein import causes precursor proteins to accumulate outside mitochondria, generating proteotoxic stress.

The cell now has both a metabolic throughput problem and a proteostasis problem.

This is a much broader picture of bioenergetic congestion.

The mitochondrion responds by reducing demand

One of the most important messages from the review is that cells do not simply continue pushing harder against these bottlenecks.

They adapt.

When mitochondrial protein import is impaired, precursor proteins accumulate in the cytosol. Cells activate stress responses that increase chaperones and proteasomal degradation while reducing the production of many mitochondrial and oxidative-phosphorylation proteins.

Mitochondrial dysfunction can also activate the OMA1–DELE1–HRI pathway, leading to phosphorylation of eIF2α and activation of the integrated stress response. General protein synthesis decreases while stress-related transcription factors such as ATF4, ATF5, and CHOP are preferentially produced.

From the cell's perspective, this makes sense.

If the mitochondrial import-and-assembly system is operating near its limit, continuing to manufacture proteins at the previous rate would worsen congestion.

The adaptive response therefore reduces incoming load while increasing repair capacity.

This resembles what we have described more broadly as the energy constraint principle: when available energetic and processing capacity becomes limited, biological systems prioritize immediate stability over growth, rebuilding, and long-term optimization.

What appears clinically as reduced anabolic activity or metabolic slowing may sometimes represent an adaptive attempt to keep cellular demand inside the system's remaining processing capacity.

Tissue permissiveness is more than blood supply

This perspective also expands the concept of tissue permissiveness.

It is tempting to think of tissue permissiveness mainly in terms of delivery:

Can sufficient blood reach the tissue?

Is oxygen available?

Are glucose, fatty acids, amino acids, vitamins, and minerals reaching the cells?

All of these remain essential.

But delivery alone does not guarantee utilization.

A tissue may receive oxygen and nutrients yet remain unable to convert them efficiently into mitochondrial function if its intracellular machinery cannot process them.

This suggests a broader sequence:

systemic availability→ vascular delivery→ cellular uptake→ mitochondrial substrate handling→ mitochondrial protein import and assembly→ respiratory throughput→ ATP-supported adaptation and recovery

A bottleneck at any point can lower tissue permissiveness.

Mitochondrial protein import is especially important because it determines the cell's ability to construct and renew the machinery needed for future energy production.

Permissiveness therefore reflects not simply whether resources arrive, but whether the tissue is capable of receiving, processing, incorporating, and using them.

A useful working definition may be:

Tissue permissiveness is the capacity of a tissue to translate available resources and signals into effective bioenergetic throughput, adaptive function, repair, and recovery.

Protein import becomes one of several intracellular determinants of that capacity.

From impedance to lock-in

This brings us to perhaps the most important implication.

Transient bioenergetic impedance may be reversible.

If an acute stress slows mitochondrial throughput, the system can temporarily reduce activity, repair damaged components, restore membrane potential, rebuild respiratory complexes, and return toward its former state.

But repeated or prolonged impedance creates a different situation.

Consider the reinforcing loop:

ETC constraint→ lower membrane potential→ reduced protein import→ incomplete respiratory-complex renewal→ proteostatic stress→ integrated stress response→ reduced protein synthesis and mitochondrial activity→ still lower respiratory capacity

At first, each step may be adaptive.

Reducing protein synthesis protects an overloaded mitochondrial system.

Fragmenting damaged mitochondria may isolate dysfunctional components.

Mitophagy removes mitochondria that cannot be repaired.

Metabolic rerouting may keep ATP production and redox balance sufficiently stable for survival.

But repeated adaptation has consequences.

If recovery is incomplete, the next stress begins from a lower functional baseline.

The system then encounters its throughput limit sooner.

More adaptation is required.

And progressively more biological organization becomes dedicated to maintaining the adapted state.

This is what we mean by bioenergetic lock-in.

Lock-in does not necessarily mean irreversible structural damage.

It describes a state in which the system has become stabilized around an adapted configuration that is increasingly costly to reverse.

Protein-import impairment provides a particularly compelling mechanism for such lock-in because it interferes with the machinery needed to rebuild the machinery.

Impedance is therefore more than insufficient ATP

This review helps clarify why mitochondrial dysfunction should not be reduced to a simple question of ATP concentration.

A cell can maintain ATP temporarily through compensation while underlying throughput becomes increasingly constrained.

Bioenergetic impedance refers instead to the resistance encountered as energy-related substrates, electrons, proteins, information, and repair processes move through the system.

A high-impedance mitochondrion may therefore show several overlapping characteristics:

• carbon substrates being rerouted because oxidative throughput is constrained;

• elevated redox pressure because electron disposal is slowed;

• declining membrane potential;

• impaired mitochondrial protein import;

• increased proteostatic surveillance;

• reduced mitochondrial protein synthesis;

• altered fusion and fission;

• increased mitophagy;

• activation of mitochondrial and integrated stress responses.

No single feature defines impedance.

The concept describes the relationship between demand, throughput capacity, and recovery.

A broader model of mitochondrial health

The review by Song and colleagues was written as a detailed examination of mitochondrial protein quality control. It does not propose the concepts of bioenergetic impedance, permissiveness, congestion, or lock-in.

But its molecular mechanisms substantially expand how those concepts can be understood.

Mitochondrial health depends on at least two continuous flows:

the flow through the machinery

and

the flow that maintains the machinery.

The first includes carbon substrates, reducing equivalents, electrons, protons, and ATP production.

The second includes protein synthesis, targeting, import, folding, assembly, repair, degradation, and mitochondrial turnover.

When either flow becomes constrained, congestion emerges.

When they constrain one another, impedance can become self-reinforcing.

And when repeated adaptation prevents complete recovery, the system may gradually become locked into a lower-throughput state.

This gives us a more comprehensive picture of tissue permissiveness.

Health is not determined merely by whether nutrients and oxygen are available.

It also depends on whether the biological network remains permissive enough to turn those resources into functional machinery, move energy through that machinery, repair it after stress, and recover sufficiently before the next challenge arrives.

That may ultimately be the more useful question:

Not simply, “Does the cell have enough energy?”

But:

“How freely can energy, material, and repair capacity move through the system—and how completely can that system rebuild itself afterward?”

Song, J., Herrmann, J. M., & Becker, T. (2021). Quality control of the mitochondrial proteome. Nature Reviews Molecular Cell Biology, 22(1), 54–70. https://doi.org/10.1038/s41580-020-00300-2